Evidence map›Paper›PMID 24586656›Full record

Trial reportPloS one2014

Prevalence of premorbid metabolic syndrome in Spanish adult workers using IDF and ATPIII diagnostic criteria: relationship with cardiovascular risk factors.

Pedro Tauler, Miquel Bennasar-Veny, Jose M Morales-Asencio, Angel A Lopez-Gonzalez, Teofila Vicente-Herrero, Joan De Pedro-Gomez, Vanessa Royo, Jordi Pericas-Beltran, Antoni Aguilo

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Socioeconomic Inequalities in Metabolic Syndrome by Age and Gender in a Spanish Working Population.International journal of environmental research and public health · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. [Workers especially sensitive to cardiovascular risk].Revista espanola de salud publica · 2019
    Article
  10. Article
  11. Differences in Metabolic Syndrome Prevalence by Employment Type and Sex.International journal of environmental research and public health · 2018
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Pedro TaulerFundamental Biology and Health Sciences Department, Universitat Illes Balears, Palma, Spain.
Miquel Bennasar-VenyResearch Group on Evidence, Lifestyles & Health, Universitat Illes Balears, Palma, Spain.
Jose M Morales-AsencioResearch Group on Evidence, Lifestyles & Health, Universitat Illes Balears, Palma, Spain.
Angel A Lopez-GonzalezPrevention of Occupational Risks in Health Services, Balearic Islands Health Service, Palma, Spain.
Teofila Vicente-HerreroPrevention of Occupational Risks, Correos, Valencia, Spain.
Joan De Pedro-GomezResearch Group on Evidence, Lifestyles & Health, Universitat Illes Balears, Palma, Spain.
Vanessa RoyoGastroenterology Services, Manacor Hospital, Manacor, Spain.
Jordi Pericas-BeltranResearch Group on Evidence, Lifestyles & Health, Universitat Illes Balears, Palma, Spain.
Antoni AguiloResearch Group on Evidence, Lifestyles & Health, Universitat Illes Balears, Palma, Spain.
Universitat de les Illes Balears · ESFundación Hospital Manacor · ESFundació Universitat-Empresa de les Illes Balears · ESHealth Research Institute of the Balearic Islands · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMetabolic Syndrome (MetS) is a complex disorder defined as a cluster of interconnected risk factors such as hypertension, dyslipidemia, obesity and high blood glucose levels. Premorbid metabolic syndrome (PMetS) is defined by excluding patients with previously diagnosed cardiovascular disease or diabetes mellitus from those suffering MetS. We aimed to determine the prevalence of PMetS in a working population, and to analyse the relationship between the diagnostic criteria of the International Diabetes Federation (IDF) and of the National Cholesterol Education Program Adult Treatment Panel III (ATPIII). The relationship between the presence of PMetS and cardiovascular risk factors was also analysed. RESEARCH METHODOLOGY/

findingsA cross-sectional study was conducted in 24,529 male and 18,736 female Spanish (white western European) adult workers (20-65 years) randomly selected during their work health periodic examinations. Anthropometrics, blood pressure and serum parameters were measured. The presence of MetS and PMetS was ascertained using ATPIII and IDF criteria. Cardiovascular risk was determined using the Framingham-REGICOR equation. The results showed MetS had an adjusted global prevalence of 12.39% using ATPIII criteria and 16.46% using IDF criteria. The prevalence of PMetS was slightly lower (11.21% using ATPIII criteria and 14.72% using IDF criteria). Prevalence in males was always higher than in females. Participants with PMetS displayed higher values of BMI, waist circumference, blood pressure, glucose and triglycerides, and lower HDL-cholesterol levels. Logistic regression models reported lower PMetS risk for females, non-obese subjects, non-smokers and younger participants. Cardiovascular risk determined with Framingham-REGICOR was higher in participants with PMetS.

conclusionsPMetS could be a reliable tool for the early identification of apparently healthy individuals who have a significant risk for developing cardiovascular events and type 2 diabetes.

Indexed as

AdultCardiovascular DiseasesCross-Sectional StudiesDiabetes Mellitus, Type 2FemaleFollow-Up StudiesHumansHypertensionMaleMetabolic SyndromeMiddle AgedObesityPrevalencePrognosisRisk FactorsSpainTriglycerides

Identifiers

PMID24586656
PMCPMC3930690
OpenAlexW1985436790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.